Oct 29 – 30, 2024
German Cancer Research Center / Communication Center
Europe/Berlin timezone

Scientific Program

 

At a glance

 

Highlights

  • Keynote lectures 
  • Flash talks 
  • Networking formats 

Key Features

  • 5 Sessions with presentations and round table discussions
  • Poster sessions 

Sessions and Confirmed Speakers

Opening Keynote

Judy Garber, Boston, US

 

Behavioral interventions for cancer prevention

Chairs: Ute Mons & Samuel Smith

Felix Naughton, Norwich, UK

Rebecca Beeken, Leeds, UK

Monika Janda, Brisbane, AU

Pauline Vidican, Lyon, FR

 

Politics of Primary Cancer Prevention Policies

Chairs: Connie Hoe & Michèle Matta

Elisabete Weiderpass, Lyon, FR

Caitlin Weiger, New Brunswick, US 

Dame Theresa Marteau, Cambridge, UK

Salvatore Vaccarella, Lyon, FR

 

 

Molecular mechanisms in the transition from normality to cancer

Chairs: Angela Goncalves & Karol Nowicki-Osuch

Sudhir Srivastava, Bethesda, US

Rama Khokha, Toronto, CA

Lachelle Weeks, Boston, US

Humam Kadara, Houston, US

 

Understanding and improving the quality of life of cancer survivors

Chairs: Karen Steindorf & Volker Arndt

Sanne Schagen, Amsterdam, NL

Joshua F. Wiley, Notting Hill, AU

Ines Vaz-Luis, Villejuif Cedex, FR

Eline van Roekel, Maastricht, NL

 

 

Cancer screening and chemoprevention

Chairs: Peter Albers & Ulrike Haug

David Weinberg, Philadelphia, US

Jack Cuzick, London, UK

Monique Roobol, Rotterdam, NL

Alicia Morgans, Boston, US

 

 

 

Closing Keynote

Cheryl Willman, Rochester, US

 

 

 

Program

Tuesday, 29th October 2024                       

 

8:30 AM          ・・・・・・・CHECK-IN & Welcome Coffee・・・・・・・・

9:00 AM          WELCOME

                        Michael Baumann, German Cancer Research Center (DKFZ), DE  
Franz Kohlhuber, German Cancer Aid, DE  
Federal Minister Bettina Stark-Watzinger, German Federal Ministry of Education and Research, DE   
Federal Minister Karl Lauterbach, German Federal Ministry of Health, DE

9:20 AM          Opening Keynote  
Chair: Ernest Hawk

Germline genetics, cancer risk, and interception strategies          
Judy Garber, Dana-Farber Cancer Institute, US

10:00 AM         ・・・・・・・Comfort break・・・・・・・

10:15 AM        SESSION Behavioral interventions for cancer prevention  
Chairs: Ute Mons & Samuel Smith

Turning promise into practice: digital innovations for supporting cancer prevention behaviors  
Felix Naughton, University of East Anglia, UK

                       Weight management interventions for cancer prevention  
Rebecca Beeken, University of Leeds, UK

                       Targeted digital approaches to skin cancer prevention and early detection  
Monika Janda,The University of Queensland, AU 

                       Prevention of modifiable cancer risks in informal family caregivers of cancer patients  
Pauline Vidican, Centre Léon Bérard, FR

11:45 AM         Rapid fire flash talks

12:00 PM         Poster session

12:45 PM        ・・・・・・・Light Lunch break・・・・・・・

1:30 PM          SESSION Politics of primary cancer prevention policies  
Chairs: Connie Hoe & Michèle Matta

Experience and perspective of the EU Cancer Mission  
Elisabete Weiderpass, International Agency for Research on Cancer, FR

Tobacco marketing as a commercial determinant of health: incomplete regulation of natural cigarette marketing in the U.S.  
Caitlin Weiger, Rutgers Institute for Nicotine and Tobacco Studies, US

                       Why are we neglecting evidence that could change our behavior and prevent 40% of cancers?  
Dame Theresa Marteau, University of Cambridge, UK

Global cancer inequalities and inefficiencies in healthcare  
Salvatore Vaccarella, International Agency for Research on Cancer, FR

3:00 PM          ・・・・・・・Comfort break・・・・・・・

3:15 PM           Networking & Career Talks                      

4:30 PM          SESSION Molecular mechanisms in the transition from normality to cancer  
Chairs: Angela Goncalves & Karol Nowicki-Osuch

Building PreCancer Atlas toward understanding the natural history of precancer 
Sudhir Srivastava, National Cancer Institute, US

Deconvoluting cancer precursors for primary cancer prevention  
Rama Khokha, Princess Margaret Cancer Centre/UHN, CA

Towards AML Prevention: Detection and Intervention in Clonal Hematopoiesis  
Lachelle Weeks, Dana-Farber Cancer Institute, US

Mapping the transition of normal tissue to lung cancer: What the cell is going on?  
Humam Kadara, MD Anderson Cancer Center, US

6:00 PM          Cancer Prevention Graduate School

6:30 PM          ・・・・・・・Get-together・・・・・・・

 


 

 

 

Wednesday, 30th October 2024            

 

8:00 AM           ・・・・・・・CHECK-IN & Welcome Coffee・・・・・・・

8:30 AM          Networking & Career Talks  

9:45 AM           ・・・・・・・Comfort break・・・・・・・

10:15 AM        WELCOME BACK & SESSION Understanding and improving the quality of life of cancer survivors  
Chairs: Karen Steindorf & Volker Arndt

Improving care for cancer patients with cognitive problems 
Sanne Schagen, Netherlands Cancer Institute, NL 

Interventions for Sleep after Cancer  
Joshua F. Wiley, Monash University, AU

Shifting toward precision survivorship medicine
Ines Vaz-Luis, Gustave Roussy, FR 

Time to unravel the role of circadian dysregulation in fatigue after colorectal cancer: project overview and first results  
Eline van Roekel, GROW Research Institute for Oncology and Reproduction, Maastricht University, NL 

Patient Panelist  
Cindy Körner, NCT Patient Research Council, DE

11:45 PM        Rapid fire flash talks

12:00 PM        Poster session          

12:45 PM        ・・・・・・・・・Light Lunch・・・・・・・・・

1:30 PM          SESSION Cancer screening and chemoprevention  
Chairs: Peter Albers & Ulrike Haug

                       Multi cancer early detection: Ready or not?  
David Weinberg, Fox Chase Cancer Center, US

Effect of oestradiol and testosterone on the efficacy of anastrozole for preventing breast cancer  
Jack Cuzick, Queen Mary University of London, UK

Population-based screening for PCa - the PRIASE-U initiative  
Monique Roobol, Erasmus MC, NL

Cancer Screening and Familial Genetic Risk: Prostate Cancer  
Alicia Morgans, Dana-Farber Cancer Institute, US

Patient Panelist  
Thomas Müldner, DKFZ Patient Advisory Council, DE

 

3:00 PM          ・・・・・・・Coffee break・・・・・・・

3:30 PM          Closing Keynote  
Chair: Philip Castle

Cancer Prevention in a Time of Transformation: From Engagement of Diverse Communities, to Genetic and AI-Driven Risk Assessment, Early Detection, Interception, and Decentralized Cancer Care and Clinical Trials
Cheryl Willman, Mayo Clinic Comprehensice Cancer Center, Rochester, US  

4:10 PM          CLOSING REMARKS

4:15 PM          ・・・・・・・・・End of conference ・・・・・・・・・